WE NOW HAVE DEDICATED FACILITIES FOR THE MANUFACTURE OF PHARMACEUTICAL COAL TAR
Coal Tar & Coal Tar Solution
Coal Tar is on the World Health Organisation List of Essential Medicines.
GMP Pharma has positioned itself as a specialist manufacturer of a complete range of bulk coal tar products, such as Coal Tar Solutions BP/USP for supply within the pharmaceutical and cosmetic industries. These are produced under strict GMP conditions, adhering to strict manufacturing processes, quality assurance measures, and regulatory compliance to ensure efficacy and safety in dermatological treatments.
The bulk supply of coal tar solution for pharmaceutical applications plays a critical role in the development and production of dermatological treatments and medications. Derived from the distillation of coal tar, this solution serves as a fundamental ingredient in various pharmaceutical formulations aimed at treating skin disorders.
Essential Ingredient in Dermatological Treatments:
Coal tar solution is a key component in the formulation of dermatological treatments for conditions such as psoriasis, eczema, and seborrheic dermatitis. Its antipruritic, anti-inflammatory, and keratolytic properties make it highly effective in alleviating symptoms and promoting skin health. Pharmaceutical companies rely on bulk supplies of coal tar solution to meet the demand for various topical preparations, including creams, ointments, lotions, and shampoos, tailored to address specific skin conditions.
Manufacturing Processes and Quality Control:
The production of coal tar solution for pharmaceutical use involves stringent manufacturing processes to ensure purity, potency, and consistency. Through fractional distillation and purification techniques, impurities are removed, and the composition of the solution is standardized to meet pharmaceutical-grade specifications. Quality control measures, including chemical analysis and microbial testing, are implemented at various stages of production to verify compliance with regulatory standards and pharmacopoeia requirements.
Regulatory Compliance and Safety Assurance:
Regulatory authorities, such as the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, impose strict guidelines on the manufacturing, storage, and distribution of pharmaceutical-grade coal tar solution. Compliance with Good Manufacturing Practice (GMP) regulations is mandatory to ensure the safety, efficacy, and quality of pharmaceutical products. Furthermore, stringent monitoring of potential contaminants and adherence to pharmacopoeia monographs guarantee the integrity of coal tar solution intended for pharmaceutical use.